Featured Image
Why is it important?
Our findings provide novel evidence regarding how hematopoietic stem/progenitor cells (HSPCs) are protective in stroke and as such provide a possible therapeutic strategy for the treatment of stroke.
Read the Original
This page is a summary of: Metallothionein I as a direct link between therapeutic hematopoietic stem/progenitor cells and cerebral protection in stroke, The FASEB Journal, January 2018, Federation of American Societies For Experimental Biology (FASEB),
DOI: 10.1096/fj.201700746r.
You can read the full text:
Contributors
The following have contributed to this page
